Entry Detail



General Information

Database ID:exR0075997
RNA Name:LDHA
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):18394560End Site(bp):18408425
External Links:ENSG00000134333



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL136454.1
chr1
192716132
192716653
+
AKIRIN1
chr1
38991276
39006059
+
AJUBA
chr14
22971177
22982551
-
ADAR
chr1
154582057
154628013
-
AC073508.2
chr17
40627356
40665141
-
AKAP11
chr13
42272152
42323261
+
AKR1A1
chr1
45550543
45570049
+
ABHD8
chr19
17292131
17310236
-
AGTRAP
chr1
11736084
11754802
+
AC006030.1
chr2
74211604
74363377
-
ADGRA3
chr4
22345071
22516066
-
ACTR2
chr2
65227753
65271253
+
AL022238.4
chr22
40346529
40410054
+
ACTR1B
chr2
97655939
97664044
-
ACTR3
chr2
113890063
113962596
+
ADCY1
chr7
45574140
45723116
+
AL139353.1
chr14
31334312
31457441
-
ACY3
chr11
67642555
67650730
-
AC004922.1
chr7
99325879
99394653
+
ACTG1
chr17
81509971
81523847
-
ABCB7
chrX
75051048
75156732
-
AL021546.1
chr12
120438198
120460006
+
AL136295.5
chr14
24147548
24166452
+
AAR2
chr20
36236459
36270918
+
AC138811.2
chr16
18788063
18801519
-
AC023055.1
chr12
55757275
55827546
-
AIP
chr11
67483026
67491103
+
AC139530.2
chr17
81703371
81720539
+
ABT1
chr6
26596953
26600739
+
ADTRP
chr6
11712054
11807046
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-302a-3p
chr4
112648186
112648208
-
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC008870.2
chr16
23670011
23675499
+
AC010442.1
chr5
466124
473098
-
AC010655.2
chr7
128455937
128469197
+
AC010655.4
chr7
128455840
128493859
+
AC012236.1
chr15
31221999
31230838
-
AC016876.2
chr17
7581964
7584086
-
AC020663.1
chr16
4730115
4752565
-
AC022098.1
chr19
14137146
14171267
+
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC091564.7
chr11
6610883
6616594
-
AC092368.3
chr16
46622861
46624451
-
AC109460.3
chr16
28974804
28990775
+
AL035458.2
chr20
34234840
34281173
-
AL117378.1
chr6
131901963
131920565
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA